Very good news to start the week. "DMX-200 is performing better than placebo..."
It would be interesting to see the data - ie. just what is the actual statistical difference between DMX-200 and placebo? However, the IDMC has recommended that the trial continue unchanged, so they must be satisfied with the result.
I look forward to the "second interim analysis point" which will again look at proteinurea, but it will also look at kidney function - and that will be critically important. After all - it's actual kidney function that will count here.
So - more waiting - but this first interim analysis is based on data from 72 patients, so we can be pretty confident that DMX-200 is shaping up as hoped. Also fabulous to see further confirmation of the excellent safety profile for DMX-200 - "no safety concerns."
Cheers
Dave
- Forums
- ASX - By Stock
- Ann: Dimerix Successfully Passes Efficacy Interim Analysis
Very good news to start the week. "DMX-200 is performing better...
- There are more pages in this discussion • 257 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
34.5¢ |
Change
-0.005(1.43%) |
Mkt cap ! $189.6M |
Open | High | Low | Value | Volume |
35.5¢ | 35.8¢ | 33.5¢ | $2.114M | 6.083M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 516070 | 34.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.5¢ | 3146 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 516070 | 0.340 |
6 | 239158 | 0.335 |
9 | 291714 | 0.330 |
7 | 267990 | 0.325 |
14 | 474804 | 0.320 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 3146 | 1 |
0.350 | 162714 | 4 |
0.355 | 478714 | 7 |
0.360 | 148219 | 5 |
0.365 | 196013 | 5 |
Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
Last
34.5¢ |
  |
Change
-0.005 ( 0.83 %) |
|||
Open | High | Low | Volume | ||
35.5¢ | 36.0¢ | 33.5¢ | 3852478 | ||
Last updated 15.59pm 07/05/2024 ? |
Featured News
DXB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
Previous Video
Next Video
SPONSORED BY The Market Online